You have 3 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSI-high Endometrial Cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Beijing (KN035)

Recruiting
  • Solid Tumor
  • KN035
  • Beijing, Beijing, China
    Peking University Cancer Hospital, Peking University
Apr 5, 2022

Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

Recruiting
  • Digestive System Cancers
  • Beijing, China
    Peking University Cancer Hospital
Oct 25, 2023

Liquid Biopsies and Tumor Molecular Profiling in Predicting

Recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Colorectal Cancer, Microsatellite Instability High Trial in Guangzhou (PD-1 inhibitor plus VEGF inhibitors)

Recruiting
  • Colorectal Cancer
  • Microsatellite Instability High
  • PD-1 inhibitor plus VEGF inhibitors
  • Guangzhou, Guangdong, China
    651 Dongfeng Road East
May 27, 2022

Middle-high Risk Endometrial Cancer, Sentinel Lymph Node Sampling, Prognosis Trial in Shanghai (sentinel lymph node sampling

Recruiting
  • Middle-high Risk Endometrial Cancer
  • +2 more
  • sentinel lymph node sampling (SLN)
  • pelvic lymphonodectomy (PLN)
  • Shanghai, Shanghai, China
    Obstetrics and Gynecology Hospital, Fudan University
Mar 24, 2022

Cervical Cancer, Endometrial Cancer Trial in United States (18F-Fluorodeoxyglucose (18F-FDG), PET/CT imaging, PET/MRI imaging)

Active, not recruiting
  • Cervical Cancer
  • Endometrial Cancer
  • 18F-Fluorodeoxyglucose (18F-FDG)
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in United

Active, not recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +5 more
  • Houston, Texas
  • +6 more
Dec 5, 2022

Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma Trial in Boston (PET/MRI

Not yet recruiting
  • Cytoreductive Surgery
  • +4 more
  • PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent
  • Boston, Massachusetts
    Massachusetts General Hospital
May 21, 2022

Endometrial Cancer Trial in Hong Kong (Olaparib)

Not yet recruiting
  • Endometrial Cancer
  • Hong Kong, Hong Kong
    The University of Hong Kong
Apr 2, 2022

Endometrial Cancer, Stage III Endometrial Cancer, Stage III Endometrial Carcinoma Trial in United States (Intensity-modulated

Recruiting
  • Endometrial Cancer
  • +4 more
  • Intensity-modulated radiation therapy
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 10, 2023

Solid Tumors, Identified by NGS, PCR or IHC Trial in United States (Pembrolizumab)

Recruiting
  • Solid Tumors
  • Identified by NGS, PCR or IHC
  • Basking Ridge, New Jersey
  • +6 more
Oct 7, 2022

Colon Cancer Trial (Tislelizumab)

Not yet recruiting
  • Colon Cancer
  • (no location specified)
Feb 7, 2022

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

Recruiting
  • Deleterious BRCA1 Gene Mutation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2022

Colorectal Cancer Trial in China (Tislelizumab)

Recruiting
  • Colorectal Cancer
  • Bengbu, Anhui, China
  • +7 more
Sep 13, 2022

Cervical Cancer, Endometrial Cancer, Esophageal Cancer Trial run by the National Cancer Institute (NCI) (HDR Brachytherapy)

Recruiting
  • Cervical Cancer
  • +4 more
  • HDR Brachytherapy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 19, 2022

Endometrial Cancer, Lymph Node Metastases Trial in Brazil (Sentinel Node Mapping, Lymphadenectomy)

Recruiting
  • Endometrial Cancer
  • Lymph Node Metastases
  • Sentinel Node Mapping
  • Lymphadenectomy
  • Curitiba, Parana, Brazil
  • +4 more
Feb 16, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Colorectal Cancer Trial in Essen (Atezolizumab)

Recruiting
  • Colorectal Cancer
  • Essen, Germany
    Westdeutsches Tumorzentrum
Feb 14, 2022

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023

Microsatellite Stable Colorectal Cancer, Pancreatic Cancer, MSI High Colorectal Cancer Trial in Boston (Nivolumab, Ipilimumab,

Recruiting
  • Microsatellite Stable Colorectal Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts general Hospital
Mar 24, 2021

Melanoma Stage IV, Unresectable Melanoma, NSCLC Stage IV Trial in Ramat Gan (Fecal Microbial Transplantation by capsules)

Recruiting
  • Melanoma Stage IV
  • +2 more
  • Fecal Microbial Transplantation by capsules
  • Ramat Gan, Israel
    Sheba Medical Center
Aug 9, 2021

Endometrial Cancer, Uterine Cancer Trial in Chapel Hill (Pembrolizumab, Hysterectomy)

Recruiting
  • Endometrial Cancer
  • Uterine Cancer
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Sep 27, 2022

Advanced Endometrial Cancer Trial (Pembrolizumab, GEN1046)

Not yet recruiting
  • Advanced Endometrial Cancer
  • (no location specified)
Sep 14, 2023

Endometrial Cancer, Papillary Serous, Clear Cell Endometrial Cancer Trial in Oklahoma City (Vaginal Cuff Brachytherapy,

Active, not recruiting
Has Results
  • Endometrial Cancer
  • +2 more
  • Vaginal Cuff Brachytherapy
  • +2 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 13, 2021